Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

Ähnliche Einträge

• The effects of cannabidiol against Methotrexate‐induced lung damage
  von: Ozlem Ozmen, et al.
  Veröffentlicht: (2024)
• The effectiveness and safety of botulinum toxin injections for managing motor disorders of patients with Parkinson's disease: A meta‐analysis of randomized controlled trials
  von: Fang Gao, et al.
  Veröffentlicht: (2024)
• Effects of quercetin in preclinical models of Parkinson's disease: A systematic review
  von: Camila de Oliveira Vian, et al.
  Veröffentlicht: (2024)
• Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update
  von: James Bluett, et al.
  Veröffentlicht: (2025)
• Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies
  von: Raimo K. Tuominen, et al.
  Veröffentlicht: (2024)